<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A significant number of studies describe the cytogenetics and molecular genetics of adult non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL); however, similar knowledge is lacking regarding <z:e sem="disease" ids="C0220612" disease_type="Neoplastic Process" abbrv="">pediatric NHL</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A workshop to discuss the "State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays" in <z:e sem="disease" ids="C0220612" disease_type="Neoplastic Process" abbrv="">pediatric NHL</z:e> was held in conjunction with the First International Symposium on Childhood and Adolescent Non-Hodgkin <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> on April 9, 2003 in New York City </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Cytogenetic characteristics of <z:e sem="disease" ids="C0220612" disease_type="Neoplastic Process" abbrv="">pediatric NHL</z:e> include 14q11.2 rearrangements in T-cell lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphomas</z:hpo> (LBL), ALK rearrangements in anaplastic large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e>), and CMYC translocations in both Burkitt and Burkitt-like <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLL</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Pediatric diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) is cytogenetically different from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> in adults, suggesting a different disease in children </plain></SENT>
<SENT sid="4" pm="."><plain>Microarray studies demonstrate three types of T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, the leukemic counterpart of LBL, that block T-cell differentiation at different stages of T-cell development, corresponding to LYL, TAL1, and HOX-expressing <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> cell lines have a unique expression profile compared to <z:mpath ids='MPATH_458'>normal</z:mpath> T-cells </plain></SENT>
<SENT sid="6" pm="."><plain>Germinal centers of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> have CMYC expression signatures, indicating that CMYC expression is ectopic and does not reflect the <z:mp ids='MP_0001532'>physiology</z:mp> of the <z:mpath ids='MPATH_458'>normal</z:mpath> cell counterpart </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Additional cytogenetic, molecular and microarray investigations of NHL in children are vital to better understand these diseases, their etiology, and differences from <z:e sem="disease" ids="C0220605" disease_type="Neoplastic Process" abbrv="">adult NHL</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>A greater understanding of <z:e sem="disease" ids="C0220612" disease_type="Neoplastic Process" abbrv="">pediatric NHL</z:e> will lead to disease-specific and patient-individualized therapies of these diseases </plain></SENT>
</text></document>